| 溶解性 | 25°C: DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | Description:IC50 Value: N/ABavisant (JNJ-31001074) is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD. Bavisant completed a phase II ADHD trial, but no results have been reported [1].in vitro: N/Ain vivo: Mean change from baseline in the total ADHD-RS-IV score at day 42 (primary efficacy endpoint) was -8.8 in the placebo group versus -9.3, -11.2 and -12.2 in the bavisant 1?mg/day, 3?mg/day and 10?mg/day groups, respectively; the change in the 10?mg/day group was not statistically superior to placebo (p=0.161), and hence statistical comparisons of the 1?mg/day and 3?mg/day groups with placebo based on a step-down closed testing procedure were not performed [2].Clinical trial: A Study to Characterize the Pharmacokinetics and Effect of Food on JNJ-31001074 in Healthy Volunteers. Phase 2 |
Bavisant,人H3受体拮抗剂
Bavisant （订货以英文为准）
编号：B126313
CAS号：929622-08-2
分子式：C19H27N3O2
分子量：329.44
| 产品名称 | Bavisant |
| 中文名称 | Bavisant,人H3受体拮抗剂 |
| CAS号 | 929622-08-2 |
| 分子式（M.F.） | C19H27N3O2 |
| 分子量（M.W.） | 329.44 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 500.00
sh6786-10mL
¥ 420.00
01484972-4L
¥ 1520.00
BWY0821011-1mL
¥ 259.00
sh24567-1个
¥ 5212.00
2106-0016-1箱
¥ 3406.00
2106-0002 -1箱
¥ 3289.00
2106-0001-1箱
¥ 510.00
P9157-50T-PKG-5T
党沛 
